Details for New Drug Application (NDA): 202543
✉ Email this page to a colleague
The generic ingredient in LEVETIRACETAM IN SODIUM CHLORIDE is levetiracetam. There are thirty-five drug master file entries for this compound. Eighty-seven suppliers are listed for this compound. Additional details are available on the levetiracetam profile page.
Summary for 202543
Tradename: | LEVETIRACETAM IN SODIUM CHLORIDE |
Applicant: | Hq Spclt Pharma |
Ingredient: | levetiracetam |
Patents: | 0 |
Pharmacology for NDA: 202543
Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Suppliers and Packaging for NDA: 202543
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LEVETIRACETAM IN SODIUM CHLORIDE | levetiracetam | INJECTABLE;INTRAVENOUS | 202543 | NDA | WG Critical Care, LLC | 44567-501 | 44567-501-10 | 10 BAG in 1 CARTON (44567-501-10) / 100 mL in 1 BAG (44567-501-01) |
LEVETIRACETAM IN SODIUM CHLORIDE | levetiracetam | INJECTABLE;INTRAVENOUS | 202543 | NDA | WG Critical Care, LLC | 44567-501 | 44567-501-90 | 10 BAG in 1 CARTON (44567-501-90) / 100 mL in 1 BAG (44567-501-02) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRAVENOUS | Strength | 500MG/100ML (5MG/ML) | ||||
Approval Date: | Nov 9, 2011 | TE: | AP | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRAVENOUS | Strength | 1GM/100ML (10MG/ML) | ||||
Approval Date: | Nov 9, 2011 | TE: | AP | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRAVENOUS | Strength | 1.5GM/100ML (15MG/ML) | ||||
Approval Date: | Nov 9, 2011 | TE: | AP | RLD: | Yes |
Complete Access Available with Subscription